Dec. 19, 2024 - Despite a strong start to the year, activist activity in Canada in 2024 tapered to pre-pandemic levels. This reversion to more historic annual totals follows a notable resurgence of shareholder demands directed at Canadian public companies in 2023, when shareholder engagement reached its...
Announcement
GSK / BELLUS Health Is Named Impact Deal of the Year
The 2024 LMG Life Sciences Awards has named BELLUS Health’s US$2-billion sale to GSK as an Impact Deal of the Year (for the Americas).
LMG Life Sciences nominates key legal players in the life sciences industry and recognizes their most outstanding work in this field. We appreciate this recognition and thank our clients for entrusting us with their most important matters.
The Davies team that acted for BELLUS Health includes Sébastien Roy, Steven Cutler, Amélie Doyon, Ryan Brun and Noah Abitbol (Corporate and Public M&A); Brian Bloom and Taj Kudhail (Tax); Charles Tingley and Dajena Pechersky (Competition, Antitrust and Foreign Investment); Hélène Bussières (Employment, Labour and Executive Compensation); Louis-Martin O’Neill and Faiz Lalani (Dispute Resolution).
Related
Federal Court of Appeal Confirms CRA Can Collect Arrears Interest Despite Absence of a Tax Debt
Dec. 04, 2024 - The Federal Court of Appeal (FCA) recently dismissed the Bank of Nova Scotia’s (BNS) appeal and upheld the Canada Revenue Agency’s (CRA) practice of charging arrears interest on a non-existent tax debt where audit adjustments increase taxable income that is offset by the carryback of a loss...
